Community walking speed, sedentary or lying down time, and mortality in peripheral artery disease
- PMID: 26873873
- PMCID: PMC5656391
- DOI: 10.1177/1358863X15626521
Community walking speed, sedentary or lying down time, and mortality in peripheral artery disease
Abstract
We studied whether slower community walking speed and whether greater time spent lying down or sleeping were associated with higher mortality in people with lower extremity peripheral artery disease (PAD). Participants with an ankle-brachial index (ABI) < 0.90 were identified from Chicago medical centers. At baseline, participants reported their usual walking speed outside their home and the number of hours they spent lying down or sleeping per day. Cause of death was adjudicated using death certificates and medical record review. Analyses were adjusted for age, sex, race, comorbidities, ABI, and other confounders. Of 1314 PAD participants, 189 (14.4%) died, including 63 cardiovascular disease (CVD) deaths. Mean follow-up was 34.9 months ± 18.1. Relative to average or normal pace (2-3 miles/hour), slower walking speed was associated with greater CVD mortality: no walking at all: hazard ratio (HR) = 4.17, 95% confidence interval (CI) = 1.46-11.89; casual strolling (0-2 miles/hour): HR = 2.24, 95% CI = 1.16-4.32; brisk or striding (>3 miles/hour): HR = 0.55, 95% CI = 0.07-4.30. These associations were not significant after additional adjustment for the six-minute walk. Relative to sleeping or lying down for 8-9 hours, fewer or greater hours sleeping or lying down were associated with higher CVD mortality: 4-7 hours: HR = 2.08, 95% CI = 1.06-4.05; 10-11 hours: HR = 4.07, 95% CI = 1.86-8.89; ⩾ 12 hours: HR = 3.75, 95% CI = 1.47-9.62. These associations were maintained after adjustment for the six-minute walk. In conclusion, slower walking speed outside the home and less than 8 hours or more than 9 hours lying down per day are potentially modifiable behaviors associated with increased CVD mortality in patients with PAD.
Keywords: cardiovascular mortality; cardiovascular risk factors; intermittent claudication; modifiable behaviors; peripheral artery disease; physical activity; sedentary; six-minute walk test.
© The Author(s) 2016.
Conflict of interest statement
The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Figures



References
-
- Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: A randomised placebo-controlled trial. Lancet. 2002;360:7–22. - PubMed
-
- Banerjee S, Vinas A, Mohammad A. Significance of an abnormal ankle-brachial index in patients with established coronary artery disease with and without associated diabetes mellitus. Am J Cardiol. 2014;113:1280–1284. - PubMed
Publication types
MeSH terms
Grants and funding
- R01-HL089619/HL/NHLBI NIH HHS/United States
- R01-HL109244/HL/NHLBI NIH HHS/United States
- R01 HL076298/HL/NHLBI NIH HHS/United States
- R01-HL64739/HL/NHLBI NIH HHS/United States
- R01 HL109244/HL/NHLBI NIH HHS/United States
- R01-HL076298/HL/NHLBI NIH HHS/United States
- Intramural NIH HHS/United States
- R01 HL064739/HL/NHLBI NIH HHS/United States
- R01 HL071223/HL/NHLBI NIH HHS/United States
- R01 HL089619/HL/NHLBI NIH HHS/United States
- R01-HL071223/HL/NHLBI NIH HHS/United States
- R01 HL083064/HL/NHLBI NIH HHS/United States
- R01-HL083064/HL/NHLBI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical